|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 02/12/02 | Bristol Myers Squibb Co. : Bristol-Myers executive charged with insider trading | RE |
| 17/12/17 | BioMarin Pharmaceutical Inc. : GSK clinches deal to buy Human Genome for $3 billion | RE |
Stock exchange
Nasdaq- $
-
0
$
| Markets | Price | Change | Volumes |
|---|
Basic data
Market Cap (USD)
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 0 | |
| -0.61% | -3.43% | +39.40% | +112.31% | 1,01900Cr | |
| -1.02% | -5.60% | +37.67% | +65.02% | 62TCr | |
| +1.11% | -0.58% | +11.10% | +77.28% | 46TCr | |
| +0.34% | -3.01% | +61.21% | +40.71% | 36TCr | |
| -0.95% | -4.05% | +21.60% | +39.37% | 33TCr | |
| -1.46% | -2.89% | +11.84% | +24.60% | 27TCr | |
| -1.35% | -5.43% | -4.69% | +8.40% | 24TCr | |
| -1.04% | -2.79% | +35.52% | +51.34% | 22TCr | |
| -1.87% | -4.10% | +30.92% | +95.33% | 18TCr | |
| Average | -0.76% | -3.39% | +27.17% | +57.15% | 36.97TCr | |
| Weighted average by Cap. | -0.60% | -3.33% | +30.52% | +68.96% |
Historical Quotes: Amylin Pharmaceuticals LLC
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- Stock
- Quotes Amylin Pharmaceuticals LLC
Select your edition
All financial news and data tailored to specific country editions
